biotech · Fibrostenotic Crohn’s disease · liver cirrhosis · AGMB
Agomab Therapeutics NV
News and analysis for Agomab Therapeutics NV on NovaPharmaNews — regulatory, clinical, and market coverage.
Tel Aviv, USA HQ
2011 Founded
20 Employees
Public company Type
AGMB · NYSE Ticker
Company details
- Status
- Public
- HQ
- Tel Aviv, USA
- Founded
- 2011
- Employees
- 20
- Programs
- 6
- Drugs
- 2
- Patents
- 4
News & analysis
NovaPharmaNews articles mentioning Agomab Therapeutics NV — regulatory, clinical, and market coverage.
News and analysis for Agomab Therapeutics NV on NovaPharmaNews — regulatory, clinical, and market coverage.